Ampio Pharmaceuticals (United States)
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Ampio announces a $22.5 million registered direct offering
Ampio Pharmaceuticals announced definitive agreements with institutional investors for a registered direct offering of 25 million common shares and warrants to purchase 15 million shares at a combined purchase price of $0.90 per share. The closing was expected on or about December 15, 2021, subject to customary conditions.